Review highlights the role of alpha-like subunits in RNA polymerase function and associated diseases.
Multisubunit RNA polymerases share a deeply conserved architectural core, yet their regulatory complexity has expanded dramatically over evolution. At the heart of this architecture lies an ancient assembly module formed by the alpha and alpha-like subunits. Originally emerging as a homodimeric scaffold in bacteria, this module was duplicated and partitioned into asymmetric heterodimers in archaea and eukaryotes. Far from serving as inert structural elements, alpha-like subunits function as organizational hubs that coordinate polymerase biogenesis, interface with initiation and regulatory factors, and - in some contexts - operate outside the holoenzyme to influence RNA processing and growth signalling pathways. Recent structural and genetic studies reveal that although the α-motif - mediated dimerization framework is highly conserved, species- and polymerase-specific tuning of alpha-like subunit interaction surfaces has generated functional diversification, with important consequences for assembly fidelity, transcriptional regulation, and disease susceptibility. Mutations in alpha-like subunits shared between RNAPI and RNAPIII underlie a ribosomopathy and leukodystrophy, while altered dosage contributes to oncogenic growth programs and proliferative signalling. These findings highlight alpha-like subunits as evolutionarily conserved yet adaptable platforms that couple transcriptional capacity to developmental and metabolic demands. By integrating structural, evolutionary, mechanistic, and clinical evidence, this review described the alpha-like subunits as central regulators of polymerase function and as emerging determinants of transcription-linked disease.
No takes yet. Share an insight, caveat, or question.
Onuoha et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: